Disposition and clinical implications of protein-bound uremic toxins

Jitske Jansen; Joachim Jankowski; Prathibha R. Gajjala; Jack F. M. Wetzels; Rosalinde Masereeuw

doi:10.1042/CS20160191

Disposition and clinical implications of protein-bound uremic toxins

Jitske Jansen, Joachim Jankowski, Prathibha R. Gajjala, Jack F. M. Wetzels, Rosalinde Masereeuw^*

^*Corresponding author for this work

Pathologie

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	1631-1647
Number of pages	17
Journal	Clinical Science
Volume	131
Issue number	14
DOIs	https://doi.org/10.1042/CS20160191
Publication status	Published - 15 Jul 2017

Keywords

CHRONIC KIDNEY-DISEASE
P-CRESYL SULFATE
ORGANIC ANION TRANSPORTER
HUMAN-SERUM-ALBUMIN
DRUG-DRUG INTERACTIONS
ACUTE-RENAL-FAILURE
INDOXYL SULFATE
BIOARTIFICIAL KIDNEY
GUT MICROBIOME
IN-VITRO

Access to Document

10.1042/CS20160191

Cite this

@article{7e887286c3624b7395a63e02e24c3df0,

title = "Disposition and clinical implications of protein-bound uremic toxins",

keywords = "CHRONIC KIDNEY-DISEASE, P-CRESYL SULFATE, ORGANIC ANION TRANSPORTER, HUMAN-SERUM-ALBUMIN, DRUG-DRUG INTERACTIONS, ACUTE-RENAL-FAILURE, INDOXYL SULFATE, BIOARTIFICIAL KIDNEY, GUT MICROBIOME, IN-VITRO",

author = "Jitske Jansen and Joachim Jankowski and Gajjala, {Prathibha R.} and Wetzels, {Jack F. M.} and Rosalinde Masereeuw",

year = "2017",

month = jul,

day = "15",

doi = "10.1042/CS20160191",

language = "English",

volume = "131",

pages = "1631--1647",

journal = "Clinical Science",

issn = "0143-5221",

publisher = "Portland Press Ltd.",

number = "14",

}

TY - JOUR

T1 - Disposition and clinical implications of protein-bound uremic toxins

AU - Jansen, Jitske

AU - Jankowski, Joachim

AU - Gajjala, Prathibha R.

AU - Wetzels, Jack F. M.

AU - Masereeuw, Rosalinde

PY - 2017/7/15

Y1 - 2017/7/15

KW - CHRONIC KIDNEY-DISEASE

KW - P-CRESYL SULFATE

KW - ORGANIC ANION TRANSPORTER

KW - HUMAN-SERUM-ALBUMIN

KW - DRUG-DRUG INTERACTIONS

KW - ACUTE-RENAL-FAILURE

KW - INDOXYL SULFATE

KW - BIOARTIFICIAL KIDNEY

KW - GUT MICROBIOME

KW - IN-VITRO

U2 - 10.1042/CS20160191

DO - 10.1042/CS20160191

M3 - Review article

C2 - 28667064

VL - 131

SP - 1631

EP - 1647

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 14

ER -